The global red biotechnology market continues its strong growth trajectory, with its valuation projected to rise from USD 606.1 billion in 2024 to USD 1,452.71 billion by 2033, registering a robust CAGR of 10.2% during the forecast period (2025–2033). The market’s expansion is fueled by increasing demand for advanced therapeutics, a growing pipeline of biologics, and...
SPARK Website
English